Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.185 EUR | -0.23% | +0.69% | -16.60% |
Mar. 21 | Transcript : Innate Pharma S.A., 2023 Earnings Call, Mar 21, 2024 | |
Mar. 06 | Innate Pharma initiates lymphoma trial | CF |
- Stock
- Equities
- Stock Innate Pharma - Euronext Paris
- News Innate Pharma